<?xml version="1.0" encoding="UTF-8"?>
<ref id="ijd15189-bib-0011">
 <label>11</label>
 <mixed-citation publication-type="journal" id="ijd15189-cit-0011">
  <string-name>
   <surname>Lebwohl</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Rivera‐Oyola</surname>
   <given-names>R</given-names>
  </string-name>, 
  <string-name>
   <surname>Murrell</surname>
   <given-names>DF</given-names>
  </string-name>. 
  <article-title>Should biologics for psoriasis be interrupted in the era of COVID‐19?</article-title>
  <source xml:lang="en">J Am Acad Dermatol</source>
  <year>2020</year>; 
  <volume>82</volume>(
  <issue>5</issue>): 
  <fpage>1217</fpage>–
  <lpage>1218</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.jaad.2020.03.031</pub-id>
  <pub-id pub-id-type="pmid">32199889</pub-id>
 </mixed-citation>
</ref>
